Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

9.1 Million Surgical Gowns Recalled By Cardinal Health; Firm Pins Sterility Woes On Contract Manufacturer

Executive Summary

More than 9 million surgical gowns used in many everyday surgical procedures, including open heart surgery and knee replacements, have been recalled because of sterility concerns. Cardinal Health Inc. has placed the blame on a contract manufacturer that made the gowns in "unapproved locations that did not maintain proper environmental conditions."

Cardinal Health Inc. has recalled more than 9 million surgical gowns used in many everyday surgical procedures, including open heart surgery and knee replacements, because of sterility concerns. The move has left health-care providers scrambling to find alternative products.

In a 21 January recall notice to customers, the company said the affected gowns – non-reinforced, fabric-reinforced and RoyalSilk non-reinforced – were distributed between 1 September 2018 and 10 January 2020. The firm stressed that gowns made before 2018 are not part of the recall.

“Of the 9.1 million gowns included in this recall, 7.7 million units were distributed to 2,807 facilities. 1.4 million were produced but not distributed,” Cardinal Health said in a release.

The gowns were also included in the company’s PreSource Kits; however, the kits are not part of the current recall and will be “subject to a separate field action at a later date,” the firm said in its recall notice. Nevertheless, “continue to segregate and discontinue use of surgical packs that include affected gowns from your current inventory.”

Cardinal Health told customers on 11 and 15 January that it couldn’t guarantee the sterility of its so-called Level 3 surgical gowns, and the US Food and Drug Administration on 16 January told customers to “immediately discontinue” using them. (See sidebar story.)

Gowns are rated on a scale that measures barrier protection; Level 3 gowns offer moderate-risk protection. To address a potential shortage of the Level 3 gowns, the device maker said it has increased its production of “similar products” and is providing Level 4 gowns to health-care providers to “help bridge the supply gap.”

Cardinal Health is pinning the blame on a contract manufacturer that made the gowns in “unapproved locations that did not maintain proper environmental conditions.”

Cardinal Health has terminated its relationship with the contract manufacturer, which is no longer registered with the FDA.

Meanwhile, the agency is urging health-care facilities to let it know if they’re facing gown shortages by emailing [email protected]. And customers with questions about their inventory of gowns should contact Cardinal Health directly at www.cardinalhealth.com/en/about-us/contact-us.html.

 

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel